{"id":330525,"date":"2026-08-08T02:30:35","date_gmt":"2026-08-08T02:30:35","guid":{"rendered":"https:\/\/www.europesays.com\/se\/330525\/"},"modified":"2026-08-08T02:30:35","modified_gmt":"2026-08-08T02:30:35","slug":"amazon-erbjuder-viktlakemedel-till-medicare-patienter-for-50-dollar-i-manaden","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/330525\/","title":{"rendered":"Amazon erbjuder viktl\u00e4kemedel till Medicare-patienter f\u00f6r 50 dollar i m\u00e5naden"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Amazon Pharmacy b\u00f6rjar leverera GLP-1-l\u00e4kemedlen Wegovy, Zepbound och Foundayo till ber\u00e4ttigade Medicare-patienter f\u00f6r 50 dollar i m\u00e5naden. Det framg\u00e5r av ett pressmeddelande fr\u00e5n Amazon.\n <\/p>\n<p>Tj\u00e4nsten ing\u00e5r i det federala Medicare GLP-1 Bridge-programmet, som l\u00f6per till den 31 december 2027. Amazon hanterar bland annat beh\u00f6righetskontroll, f\u00f6rhandsgodk\u00e4nnande och fakturering samt erbjuder kostnadsfri hemleverans. Leverans samma dag finns i fler \u00e4n 3 100 amerikanska orter och kr\u00e4ver inget Prime-medlemskap.\n <\/p>\n<p>Seeking Alpha uppger att den amerikanska myndigheten CMS \u00f6ppnade tillg\u00e5ngen till GLP-1-l\u00e4kemedel mot fetma f\u00f6r Medicare-patienter i juli. L\u00e4kemedlen i programmet kommer fr\u00e5n Novo Nordisk och Eli Lilly.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Samuel Alaei<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Amazon Pharmacy b\u00f6rjar leverera GLP-1-l\u00e4kemedlen Wegovy, Zepbound och Foundayo till ber\u00e4ttigade Medicare-patienter f\u00f6r 50 dollar i m\u00e5naden. Det&hellip;\n","protected":false},"author":2,"featured_media":330526,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[6302,72,70,71,6631,6456,6457,34,31,33,32,30],"class_list":["post-330525","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-amazon-com","tag-business","tag-economy","tag-ekonomi","tag-eli-lilly","tag-novo-nordisk-adr","tag-novo-nordisk-b","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117057540737678030","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/330525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=330525"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/330525\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/330526"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=330525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=330525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=330525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}